No Data
No Data
No Data
No Data
No Data
Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference
NEW YORK, April 11, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
GlobeNewswireApr 11 19:30
Companies Like Anavex Life Sciences (NASDAQ:AVXL) Are In A Position To Invest In Growth
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose mo
Simply Wall StApr 5 20:00
Anavex Life Sciences(AVXL.US) Officer Sells US$374.97K in Common Stock
$Anavex Life Sciences(AVXL.US)$ Officer MISSLING CHRISTOPHER U sold 73,380 shares of Common Stock on Mar 28, 2024 at an average price of $5.11 for a total value of $374.97K.Source: Announcement What i
Futu NewsApr 2 06:41
Form 144 | Anavex Life Sciences(AVXL.US) Officer Proposes to Sell 371.3K in Common Stocks
SEC FILLINGS DISCLOSED/ Mar 28, $Anavex Life Sciences(AVXL.US)$ Officer MISSLING CHRISTOPHER U intends to sell 73,380 shares of its common stock on Mar 28, with a total market value of approximately $
Futu NewsMar 28 20:39
Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of
GlobeNewswireMar 25 19:30
Anavex Life Sciences Announced That The First Patient In Its Phase 2 Study Of ANAVEX3-71 For Schizophrenia Has Been Screened Ahead Of Schedule
Anavex Life Sciences Announced That The First Patient In Its Phase 2 Study Of ANAVEX3-71 For Schizophrenia Has Been Screened Ahead Of Schedule
BenzingaMar 18 19:35
No Data
No Data